tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nuvectis Pharma 2.7M share Spot Secondary priced at $5.00

The deal priced below last closing price of $7.00. Lucid Capital is acting as sole book running manager for the offering.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1